ARCHIVES

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Ontak Approved For Lymphoma

October 31, 2008

In Brief: Strohl Leads Oncology Nursing Society; ONS Seeks Nominees For Consumer Panel

June 4, 1999

Clearinghouse Agrees On Three Big New Carcinogens

May 4, 1979

NCI Receives 165 SBIR Grant Applications; Combines With Solid Contracts, No More Fiascos Are Expected

June 14, 1985

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014

NCI Diet Guideline Outlined At Senate Hearing

November 22, 1985